C9orf72 hexanucleotide repeat expansions impair microglial response in ALS

C9orf72六核苷酸重复序列扩增会损害ALS中的小胶质细胞反应。

阅读:2
作者:Pegah Masrori # ,Baukje Bijnens #,Laura Fumagalli #,Kristofer Davie,Suresh Kumar Poovathingal,Tim Meese,Annet Storm,Nicole Hersmus,Raheem Fazal,Diede van den Biggelaar,Bob Asselbergh,Roxane Gruel,Johanna Van Den Daele,Heidi Denton,Paula Polanco Miquel,Simona Manzella,Winnok H De Vos ,Siddhartan Chandran ,Ludo Van Den Bosch,Dietmar Rudolf Thal,Renzo Mancuso,Philip Van Damme

Abstract

Microglia and neuroinflammation are involved in amyotrophic lateral sclerosis (ALS), but the precise underlying molecular mechanisms remain elusive. We generated single-nuclei transcriptomes from the spinal cord and motor cortex of patients with sporadic ALS (sALS) and C9orf72 ALS (C9-ALS). Here we confirmed that C9orf72 is highly expressed in microglia and observed that the hexanucleotide repeat expansion (HRE) results in haploinsufficiency. Whereas sALS microglia transitioned toward disease-associated cell states, C9orf72 HRE microglia exhibited a diminished response, with alterations in endolysosomal pathways. We confirmed these observations using a human microglia xenograft model, in which C9orf72 mutations led to a reduced activation. We also confirmed the endolysosomal alterations in C9orf72 HRE and C9orf72-deficient induced pluripotent stem cell (iPSC)-derived microglia. We also found a diminished response of C9orf72 HRE astrocytes and provided a map of dysregulated ligand-receptor pairs in microglia and astrocytes. Our data highlight variations in the cellular substrate of sporadic and inherited forms of ALS, which have implications for patient stratification and selection of appropriate treatments.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。